Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules

Open access
Silvestri, Gerard A., Tanner, Nichole T., Kearney, Paul, Vachani, Anil, Massion, Pierre P., Porter, Alexander, Springmeyer, Steven C., Fang, Kenneth C., Midthun, David, Mazzone, Peter J., Silvestri, G.A., Leake, L., Mazzone, P., Beukemann, M., Midthun, D., McCarthy, P., Sigal, B., Deluca, T., Laberge, F., Fortin, B., Balaan, M., Dimitt, B., Pierre, A., Allison, F., Yarmus, L., Oakjones-Burgess, K., Tanner, N., Leake, L., Ettinger, N., Setchfield, T., Madtes, D., Hubbard, J., McConnell, W., Robinson, K., Lackey, A., Jacques, L., Kuo, E., Markland-Gentles, V., Massion, P., Muterspaug, A., Leach, J., Rothe, K., Rom, W., Pass, H., Sorenson, A., Chesnutt, A., Georgeson, A., Balekian, A., Fisher, J., Murali, R., Overton, A., Desai, N., Levesque, A., Krimsky, W., King, S., Vachani, A., Maletteri, K., Mileham, K., Carter, L., Hong, G., Ma, J., Voelker, K., Barrentine, H., Aronson, R., Henderson, M., Lamberti, J., Krawiecki, C., Case, A., Wilkins, L., Ayers, J.M., Fangmann, K., Landis, J., DeSouza, L., Hammoud, Z., Kah, D., Sanchez, J., Murdoch, L.·2018·Chest

Abstract

BACKGROUND: Lung nodules are a diagnostic challenge, with an estimated yearly incidence of 1.6 million in the United States. This study evaluated the accuracy of an integrated proteomic classifier in identifying benign nodules in patients with a pretest probability of cancer (pCA) ≤ 50%. METHODS: A prospective, multicenter observational trial of 685 patients with 8- to 30-mm lung nodules was conducted. Multiple reaction monitoring mass spectrometry was used to measure the relative abundance of two plasma proteins, LG3BP and C163A. Results were integrated with a clinical risk prediction model to identify likely benign nodules. Sensitivity, specificity, and negative predictive value were calculated. Estimates of potential changes in invasive testing had the integrated classifier results been available and acted on were made. RESULTS: A subgroup of 178 patients with a clinician-assessed pCA ≤ 50% had a 16% prevalence of lung cancer. The integrated classifier demonstrated a sensitivity of 97% (CI, 82-100), a specificity of 44% (CI, 36-52), and a negative predictive value of 98% (CI, 92-100) in distinguishing benign from malignant nodules. The classifier performed better than PET, validated lung nodule risk models, and physician cancer probability estimates (P < .001). If the integrated classifier results were used to direct care, 40% fewer procedures would be performed on benign nodules, and 3% of malignant nodules would be misclassified. CONCLUSIONS: When used in patients with lung nodules with a pCA ≤ 50%, the integrated classifier accurately identifies benign lung nodules with good performance characteristics. If used in clinical practice, invasive procedures could be reduced by diverting benign nodules to surveillance. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01752114; URL: www.clinicaltrials.gov).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chest.2018.02.012

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 165

Metadata

Authors
Silvestri, G. A., Tanner, N. T., Kearney, P., Vachani, A., Massion, P. P., Porter, A., Springmeyer, S. C., Fang, K. C., Midthun, D., Mazzone, P. J., Silvestri, G. A., Leake, L., Mazzone, P., Beukemann, M., Midthun, D., McCarthy, P., Sigal, B., Deluca, T., Laberge, F., Fortin, B., Balaan, M., Dimitt, B., Pierre, A., Allison, F., Yarmus, L., Oakjones-Burgess, K., Tanner, N., Leake, L., Ettinger, N., Setchfield, T., Madtes, D., Hubbard, J., McConnell, W., Robinson, K., Lackey, A., Jacques, L., Kuo, E., Markland-Gentles, V., Massion, P., Muterspaug, A., Leach, J., Rothe, K., Rom, W., Pass, H., Sorenson, A., Chesnutt, A., Georgeson, A., Balekian, A., Fisher, J., Murali, R., Overton, A., Desai, N., Levesque, A., Krimsky, W., King, S., Vachani, A., Maletteri, K., Mileham, K., Carter, L., Hong, G., Ma, J., Voelker, K., Barrentine, H., Aronson, R., Henderson, M., Lamberti, J., Krawiecki, C., Case, A., Wilkins, L., Ayers, J. M., Fangmann, K., Landis, J., DeSouza, L., Hammoud, Z., Kah, D., Sanchez, J., & Murdoch, L.
Venue
Chest
Publisher
Elsevier BV
Published
2018-09
Volume
154
Issue
3
Pages
491-500
ISSN
0012-3692 (ISSN-L)
OpenAlex
W2788104423
Cited by
165
References
1
FWCI
10.31
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules. https://app.cochat.ai/papers/10.1016/j.chest.2018.02.012
The paper
Silvestri, G. A., Tanner, N. T., Kearney, P., Vachani, A., Massion, P. P., Porter, A., Springmeyer, S. C., Fang, K. C., Midthun, D., Mazzone, P. J., Silvestri, G. A., Leake, L., Mazzone, P., Beukemann, M., Midthun, D., McCarthy, P., Sigal, B., Deluca, T., Laberge, F., . . . Murdoch, L. (2018). Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules. Chest. https://doi.org/10.1016/j.chest.2018.02.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.